• Company
• GSK challenges Meningococcal serogroup B mkt with Bexsero
• by Hwang, Byung-woo Jul 18, 2024 05:49am

• Company
• Organon introduces JADA system for postpartum hemorrhage
• by Hwang, Byung-woo Jul 18, 2024 05:48am

• Company
• ProGen expands bi-specific antibody R&D with Korean partners
• by Son, Hyung-Min Jul 17, 2024 05:50am

• Company
• Botulinum toxin exports in 1H rise 17%
• by Kim, Jin-Gu Jul 17, 2024 05:50am

• Company
• Ultomiris gets expanded indication for neuromyelitis optica
• by Hwang, Byung-woo Jul 17, 2024 05:50am

• Company
• Will Eylea K-biosimilar overcome evergreening in the U.S.?
• by Hwang, Byung-woo Jul 16, 2024 05:48am

• Company
• Bladder cancer drug Balversa lands in KOR 1.5yr after apvl
• by Eo, Yun-Ho Jul 15, 2024 05:47am

• Company
• Severe asthma drug 'Fasenra' lands in general hospitals
• by Eo, Yun-Ho Jul 15, 2024 05:47am

• Company
• K-Bios make progress in new rare lung cancer drug dev
• by Son, Hyung-Min Jul 15, 2024 05:47am

• Company
• K-Bio speeds up novel drug development to treat MASH
• by Son, Hyung-Min Jul 15, 2024 05:47am